好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV+ Men on ART
Infectious Disease
(-)
319
Authors/Disclosures
Shibani S. Mukerji, MD, PhD (Massachusetts General Hospital)
PRESENTER
Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Dana H. Gabuzda, MD (Dana-Farber Cancer Inst.) Dr. Gabuzda has nothing to disclose.